Investment Rating - The report rates the AI precision medicine industry as having a positive investment outlook, with significant growth potential driven by technological advancements and policy support [10][39]. Core Insights - AI precision medicine is transforming healthcare from experience-based to data-driven approaches, emphasizing personalized treatment through genetic testing and big data [9][10]. - The market for AI precision medicine is expected to grow rapidly, with projections indicating a market size of 351 billion RMB by 2024 and 760 billion RMB by 2028, reflecting a compound annual growth rate (CAGR) of 21.49% [39]. - The integration of AI technologies into healthcare is enhancing diagnostic accuracy, treatment efficiency, and patient experience, addressing the challenges of uneven resource distribution in the healthcare system [17][40]. Summary by Sections Evolution of AI Precision Medicine - The evolution of AI precision medicine has progressed from research achievements to clinical applications, with significant advancements in technology and policy frameworks supporting this transition [8][9]. Policy Support - Policies are driving the development of a comprehensive and accessible precision medicine framework, enhancing regulatory systems and approval processes to facilitate the integration of AI in healthcare [10][11]. Market Trends - The AI precision medicine market is expanding rapidly, with a projected CAGR of 19.8% from 2022 to 2024 and 21.49% from 2024 to 2028, indicating strong growth potential [37][39]. Technological Advancements - AI technologies are significantly improving diagnostic capabilities, with advancements in multi-modal data integration and real-time health monitoring enhancing patient care and treatment outcomes [26][71]. Application Scenarios - AI is being applied in various healthcare settings, including personalized treatment plans, early disease detection, and long-term health management, thereby transforming traditional healthcare models [43][40]. Industry Collaboration - The report highlights the importance of collaboration across the healthcare ecosystem, leveraging data and AI to create a more integrated and efficient healthcare delivery system [78][79].

Group 1 - The core issue highlighted is the increased risk of severe outcomes and prolonged recovery for patients with chronic diseases such as hypertension and diabetes when they contract infectious diseases like influenza and shingles [1][2] - The current public health landscape in China is characterized by both opportunities and challenges, with seasonal fluctuations in respiratory infections and the persistent risks from COVID-19, monkeypox, and shingles [1] - The prevalence of chronic non-communicable diseases is rising, particularly among younger populations, necessitating a focus on integrated management of multiple diseases [1][2] Group 2 - Multi-disease management is identified as a key strategy to address current health governance challenges and is essential for the high-quality development of public health services [2] - The integration of disease prevention, diagnosis, treatment, and rehabilitation into a cohesive service model is central to the concept of medical and preventive integration [2] - The promotion of adult vaccination is presented as a practical example of medical and preventive integration, with various innovative services being implemented across multiple regions in China [2]